JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance is a research paper published in Carcinogenesis (2021). On theSindex it has a DataRank of 0.688. It has been cited 97 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.688
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01 CA226746
National Cancer Institute
Grant: R01CA233662
National Cancer Institute
Grant: P30 CA072720
National Institutes of Health
Grant: R01 CA239093
National Institutes of Health
Grant: HHSN 2612008000001E
New Jersey Health Foundation
Grant: ISFP 7
New Jersey Commission on Spinal Cord Research
Grant: CSR 19IRG014
V Foundation
Grant: T2019-012
NCI NIH HHS
Grant: K22 CA140719
NCI NIH HHS
Grant: F30 CA196103
NCI NIH HHS
Grant: R01 CA190578
New York Medical College
National Institute on Minority Health and Health Disparities
American Lung Association
Rutgers Cancer Institute of New Jersey
NIMHD NIH HHS
FWCI
5.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 1 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 8 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 8 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 5 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 4 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 3 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 7 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 7 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 5 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 2 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 2 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 6 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 4 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 6 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
Additional file 3 of Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer